Century Therapeutics

OverviewSuggest Edit

Century Therapeutics is a biotech company that develops therapies to treat cancer. It develops an allogeneic cell therapy platform that includes induced pluripotent stem cells to incorporate multiple transgenes and remove target genes. The company produces immune effector cell products that target solid tumors and hematological cancer. 

TypePublic
Founded2018
HQPhiladelphia, PA, US
Websitecenturytx.com

Latest Updates

Employees (est.) (Apr 2021)107
Share Price (Sept 2021)$24.8(-15%)
Cybersecurity ratingBMore

Key People/Management at Century Therapeutics

Lalo Flores

Lalo Flores

CEO, Director
Hy Levitsky

Hy Levitsky

President of Research & Development
Luis Borges

Luis Borges

Chief Scientific Officer
Greg Russotti

Greg Russotti

Chief Technology Officer
Adrienne Farid

Adrienne Farid

Chief Operations Officer
Shane Williams

Shane Williams

Chief People Officer
Show more

Century Therapeutics Office Locations

Century Therapeutics has offices in Philadelphia, Seattle and Hamilton
Philadelphia, PA, US (HQ)
3675 Market St
Seattle, WA, US
188 E Blaine St
Hamilton, CA
270 Longwood Rd S
Show all (3)

Century Therapeutics Financials and Metrics

Century Therapeutics Revenue

Market capitalization (17-Sept-2021)

1.4b

Closing stock price (17-Sept-2021)

24.8
Century Therapeutics's current market capitalization is $1.4 b.
Show all financial metrics

Century Therapeutics Cybersecurity Score

Cybersecurity ratingPremium dataset

B

85/100

SecurityScorecard logo

Century Therapeutics Online and Social Media Presence

Embed Graph

Century Therapeutics News and Updates

Century Therapeutics Announces Its Addition to the Russell 2000® Index

PHILADELPHIA, Sept. 17, 2021 (GLOBE NEWSWIRE) -- Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in immuno-oncology, today announced that it will be added to the small-cap Russell 2000® Index as a part …

Century Therapeutics Reports Second Quarter 2021 Financial Results and Business Updates

Continued Company investment across our iPSC platforms, programs, and manufacturingLead program, CNTY-101, remains on track for IND filing in mid-2022Recent IPO with net proceeds of approximately $221MJune 30, 2021 cash, cash equivalents, and marketable securities of $440M

Century Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

PHILADELPHIA, June 22, 2021 (GLOBE NEWSWIRE) -- Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in immuno-oncology, today announced the closing of its initial public offering of 12,132,500 shares of its…

Century Therapeutics Announces Pricing of Initial Public Offering

PHILADELPHIA, June 17, 2021 (GLOBE NEWSWIRE) -- Century Therapeutics, an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in immuno-oncology, today announced the pricing of its initial public offering of 10,550,000 shares of its common stock a…

Biotech Century Therapeutics to offer 10.6 million shares in IPO, priced at $18 to $20 each

Biotech Century Therapeutics Inc. set terms for its initial public offering on Monday, with plans to offer 10.6 million shares priced at $18 to $20 each. The company has applied to list on Nasdaq, under the ticker symbol "IPSC." JP Morgan, BofA Securities, SVB Leerink and Piper Sandler are underwri…

Century Therapeutics Expands Board of Directors with Key Appointments

PHILADELPHIA, May 5, 2021 /PRNewswire/ -- Century Therapeutics, a leading cell therapy company developing induced pluripotent stem cell (iPSC)-derived cell therapies in immuno-oncology, today announced the appointment of Joe Jimenez as Board Chair and Cynthia Butitta as a new Independent...
Show more

Century Therapeutics Frequently Asked Questions

  • When was Century Therapeutics founded?

    Century Therapeutics was founded in 2018.

  • Who are Century Therapeutics key executives?

    Century Therapeutics's key executives are Lalo Flores, Hy Levitsky and Luis Borges.

  • How many employees does Century Therapeutics have?

    Century Therapeutics has 107 employees.

  • Who are Century Therapeutics competitors?

    Competitors of Century Therapeutics include Dendreon, Vaccitech and Ikena Oncology.

  • Where is Century Therapeutics headquarters?

    Century Therapeutics headquarters is located at 3675 Market St, Philadelphia.

  • Where are Century Therapeutics offices?

    Century Therapeutics has offices in Philadelphia, Seattle and Hamilton.

  • How many offices does Century Therapeutics have?

    Century Therapeutics has 3 offices.